# THE INSTITUTE FOR CANCER VACCINES AND IMMUNOTHERAPY

## Details

- **Country:** England &amp; Wales
- **Charity number:** 1080343
- **Other names:** THE CANCER VACCINE INSTITUTE LIMITED, CVI
- **Status:** Registered
- **Legal form:** Charitable company
- **Company number:** [03884777](https://find-and-update.company-information.service.gov.uk/company/03884777)
- **Registered:** April 14, 2000
- **Register:** https://register-of-charities.charitycommission.gov.uk/en/charity-search/?p_p_id=uk_gov_ccew_onereg_charitydetails_web_portlet_CharityDetailsPortlet&amp;p_p_lifecycle=0&amp;p_p_state=maximized&amp;p_p_mode=view&amp;_uk_gov_ccew_onereg_charitydetails_web_portlet_CharityDetailsPortlet_regId=1080343


## Contact

- **Address:** UNIT 15 ABBEVILLE MEWS, 88 CLAPHAM PARK ROAD, LONDON
- **Postcode:** SW4 7BX
- **Phone:** 0845 602 0662
- **Email:** info@cancervaccine.org.uk
- **Website:** www.icvi.org.uk



## Activities

**Objects:** THE ADVANCEMENT OF EDUCATION AND THE PROTECTION AND PRESERVATION OF PUBLIC HEALTH BY PROMOTING RESEARCH INTO THE TREATMENT OF CANCER BY VACCINE TECHNOLOGY, AND BY PROMOTING THE DISSEMINATION OF THE USEFUL RESULTS OF SUCH RESEARCH.

**Activities:** The principal activity of the charity is the advancement of education and the protection and preservation of public health by promoting research into the treatment of cancer by vaccine technology and by promoting the dissemination of the useful results of such research.




## Classification

- **How:** Makes Grants To Individuals, Makes Grants To Organisations, Sponsors Or Undertakes Research
- **What:** Education/training, The Advancement Of Health Or Saving Of Lives
- **Who:** The General Public/mankind



## Geography

- Throughout England And Wales





## Trustees

| Name | Role | Appointed |
|---|---|---|
| **Sir HENRY RICHARD GEERS COTTERELL Bt OBE** | Chair |  |
| ALEXANDER CHARLES JOHNS |  | April 18, 2018 |
| GUY EDMUND SANGSTER |  |  |
| JEMMA KATE NATASHA FREEMAN |  |  |
| MRS RESHMA ASHRAF MASON |  |  |
| Saffron Emily Rankin Guy |  | Sept. 3, 2019 |




